LFST
LifeStance Health Group Inc.
$4.90
-$0.01(-0.20%)
35
Overall
50
Value
20
Tech
--
Quality
Market Cap
$2.11B
Volume
1.28M
52W Range
$3.74 - $8.61
Target Price
$8.38
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Total Revenue | $667.5M | $859.5M | $1.1B | $1.3B | ||
| Total Revenue | $667.5M | $859.5M | $1.1B | $1.3B | ||
| COST OF GOODS SOLD | ||||||
| Cost of Revenue | -- | $622.5M | $753.6M | $848.6M | ||
| GROSS PROFIT | ||||||
| Gross Profit | $667.5M | $237.0M | $1.1B | $402.4M | ||
| OPERATING EXPENSES | ||||||
| Operating Expenses | $953.9M | $447.2M | $1.2B | $1.3B | ||
| Selling, General & Administrative | $899.7M | $1.0B | $410.8M | $363.1M | ||
| Selling & Marketing Expenses | $11.7M | $8.6M | $9.4M | $12.6M | ||
| General & Administrative Expenses | $899.7M | $1.0B | $410.8M | $363.1M | ||
| Promotion & Advertising | $11.7M | $8.6M | $9.4M | $12.6M | ||
| Salaries & Wages | -- | $187.4M | $99.4M | $76.2M | ||
| Depreciation & Amortization | $54.1M | $69.2M | $80.4M | $71.0M | ||
| Depreciation & Amortization | $54.1M | $69.2M | $80.4M | $71.0M | ||
| Amortization | $1.2B | $1.3B | $1.3B | $1.3B | ||
| Other Operating Expenses | $1.5M | $218.0K | $112.0K | $363.0K | ||
| OPERATING INCOME | ||||||
| Operating income | $-286.4M | $-210.2M | $-189.1M | $-31.6M | ||
| EBITDA | $-238.3M | $-141.7M | $-104.9M | $41.5M | ||
| NON-OPERATING ITEMS | ||||||
| Interest Expense (Non-Operating) | $38.9M | $19.9M | $21.2M | $26.5M | ||
| Net Non-Operating Interest Income/Expense | $-38.9M | $-19.9M | $-21.2M | $-26.5M | ||
| Other Income/Expense | $6.4M | $-2.6M | $-7.0M | $5.0M | ||
| Other Special Charges | $-6.4M | $-3.4M | $2.4M | $-5.0M | ||
| SPECIAL ITEMS | ||||||
| Restructring And Mn A Income | -- | -- | $4.7M | -- | ||
| Special Income Charges | -- | -- | $-4.7M | -- | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-294.2M | $-212.8M | $-185.4M | $-31.1M | ||
| Pre-Tax Income | $-333.1M | $-232.7M | $-206.6M | $-57.6M | ||
| INCOME TAX | ||||||
| Tax Provision | $-25.9M | $-17.2M | $-20.3M | $-170.0K | ||
| NET INCOME | ||||||
| Net Income | $-307.2M | $-215.6M | $-186.3M | $-57.4M | ||
| Net Income (Continuing Operations) | $-307.2M | $-215.6M | $-186.3M | $-57.4M | ||
| Net Income (Discontinued Operations) | $-307.2M | $-215.6M | $-186.3M | $-57.4M | ||
| Net Income (Common Stockholders) | $-343.9M | $-215.6M | $-186.3M | $-57.4M | ||
| Normalized Income | -- | -- | -- | $-57.8M | ||
| TOTALS | ||||||
| Total Expenses | $953.9M | $1.1B | $1.2B | $1.3B | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $327.5K | $355.3K | $367.5K | $379.1M | ||
| Average Shares Outstanding (Diluted) | $327.5K | $353.4M | $367.5K | $379.1M | ||
| Shares Outstanding | $374.3M | $376.4M | $380.7M | $388.9M | ||
| Basic EPS | $-1.05 | $-0.61 | $-0.51 | $-0.15 | ||
| Basic EPS (Continuing Operations) | $-1.05 | $-0.61 | $-0.51 | $-0.15 | ||
| Diluted EPS | $-1.05 | $-0.61 | $-0.51 | $-0.15 | ||
| Diluted EPS (Continuing Operations) | -- | $-0.61 | $-0.51 | $-0.15 | ||
| OTHER METRICS | ||||||
| Accretion On Preferred Stock | $36.8M | -- | -- | -- | ||
| Gain On Sale Of P P E | -- | -- | $4.6M | -- | ||
| Non Recurring Operation Expense | -- | -- | $-50.0M | -- | ||
| Other Gand A | $899.7M | $1.0B | $410.8M | $363.1M | ||
| Otherunder Preferred Stock Dividend | $36.8M | -- | -- | -- | ||
| Preferred Stock Dividends | $36.8M | -- | -- | -- | ||
| Rent And Landing Fees | $35.4M | -- | -- | -- | ||
| Restruct | -- | -- | $4.7M | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LFST | $4.90 | -0.2% | 1.28M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get LifeStance Health Group Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW